Pegs Boston Summit
02
May
-
06
May
2022
When
Boston
Nevada
USA
Where

PEGS Boston Summit highlights a wide spectrum of biologic drug development with in-depth presentations on protein and antibody engineering, immunotherapy, oncology, expression, analytical, immunogenicity, and more.

Similar Events

You May Like

Event

Cambridge Healthtech Institute

0/5
(0)

Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.

02 - 06 May 2022
Hybrid

Speakers and Delegates
Industry Experts and Thought Leaders

Assistant Professor
Executive Director, Oncology Research
Vice President of Drug Discovery

Sponsors and Exhibitors
Brand, Media and Promotional Partners

Bio-techne

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tiss

AbCellera

Abcellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease.

Berkeley Lights, Inc.

Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products for our customers.

Applied BioMath

Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development.

AlivaMab Discovery Services

AlivaMab Discovery Services is a leader in the discovery of antibody therapeutics, trusted by top-tier pharmaceutical and biotechnology companies to deliver panels of drug-quality human antibodies.

evitria AG

?evitria is specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies).

Organizer

Get emails from us

Thank you
Oops! Something went wrong